Sunshine Biopharma Inc. Business Combination, Consideration Transferred
Sunshine Biopharma Inc. (SBFM) reported Business Combination, Consideration Transferred of $676.75 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-20.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2019-05-20
- Sunshine Biopharma Inc. business combination, consideration transferred for the quarter ending 2019-03-31 was $676.75K.
- Sunshine Biopharma Inc. business combination, consideration transferred for the quarter ending 2018-09-30 was $0.00.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month | Business Combination, Consideration Transferred 9 month |
|---|---|---|---|
| 2019-03-31 | $676.75K 10-Q · filed 2019-05-20 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $684.70K 10-Q · filed 2018-11-16 | |
| 2018-06-30 | $684.70K 10-Q · filed 2018-08-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |